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Background: Apolipoprotein-B (apo B) and Non-High Density Lipoprotein-cholesterol (non-HDL-C) are more strongly associated with 
cardiovascular (CV) risk than low-density lipoprotein cholesterol. Though apo B and non-HDL-C are correlated, significant discordances can 
exist among certain individuals. We evaluated the relationship between apo B and non-HDL-C, assessed apo B/non-HDL-C ratio as a method to 
understand their agreement/concordance in a clinically understandable fashion and to identify predictors of discordant values.
methods: We performed a chart review of new patient visits to the University of Michigan Lipid Management Clinic from January 2004 to June 
2010. Patient factors associated with the apo B/non-HDL-C ratio were assessed. Pearson’s correlation coefficients and Bland-Altman plot were 
used to investigate the relationship between apo B and non-HDL-C. Logistic regression models were used to determine the effects of patient’s 
demographic and clinical characteristics on apo B/non-HDL-C.
results: We identified a total of 672 patients (57% male; mean age: 52 ± 14 years). Mean apo B and non-HDL-C were 117.3 ± 36.6 and 198.6 ± 
86.7 mg/dL, respectively and were moderately correlated (r=0.61, p<0.001). The mean apo B/non-HDL-C ratio was 0.62 ± 0.12. Ratios 0.1 different 
from the mean were pre-specified per standard deviation to be patients with discordant values. Ninety (13.4%) patients had values 0.72. Significant 
predictors of a high apo B/non-HDL-C ratio in multivariate analyses were systolic blood pressure and HDL-cholesterol, while triglycerides and total 
cholesterol were associated with low ratio.
conclusions: Though apo B and non-HDL-C are moderately correlated, they can be highly discordant among some individuals. Several predictors 
can help identify patients with discordant values; however, the clinical meaning (i.e., CV risk) of a high apo B compared to non-HDL-C (or vise versa) 
remains to be established.
